Richard H. Scheller is EVP-RESEARCH at GENENTECH INC (DNA). They have made 38 open-market trades across 8 companies since 2006, most recently 2026-06-17.
CIK 0001214133
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $20K since 2017, against 37 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MAZE | SELL | 2025-09-15 | 2025-09-16 | $22.37 | $928K | +18.0% | +24.3% | +73.5% |
| ALEC | SELL | 2024-08-22 | 2024-08-23 | $5.16 | $228K | -14.9% | +2.6% | -29.2% |
| DICE | SELL | 2023-05-05 | 2023-05-09 | $38.51 | $6.5M | -15.2% | -15.4% | +23.4% |
| ME | SELL | 2022-11-11 | 2022-11-14 | $3.24 | $119K | -16.3% | -15.7% | -19.8% |
| BBIO | SELL | 2021-08-04 | 2021-08-06 | $53.23 | $1.5M | -9.8% | -4.1% | -4.5% |
| ALEC | SELL | 2021-07-02 | 2021-08-09 | $28.20 | $3.7M | -8.4% | -20.1% | -8.2% |
| ORIC | SELL · 10b5-1 | 2021-05-20 | 2021-05-24 | $25.14 | $50K | -15.6% | -22.1% | -11.2% |
| ORIC | SELL | 2021-05-14 | 2021-05-18 | $25.36 | $318K | -6.2% | -20.0% | -22.5% |
| ORIC | SELL · 10b5-1 | 2021-05-11 | 2021-05-13 | $25.10 | $13K | -7.4% | -18.9% | -26.2% |
| ORIC | SELL · 10b5-1 | 2021-04-28 | 2021-04-30 | $25.14 | $8K | -0.0% | -4.7% | -28.8% |
| ORIC | SELL · 10b5-1 | 2021-04-01 | 2021-04-05 | $25.00 | $5K | -9.9% | -3.8% | -25.6% |
| BBIO | SELL | 2020-12-21 | 2020-12-23 | $65.31 | $7.9M | -7.7% | -0.1% | -5.4% |
| BBIO | SELL | 2020-12-18 | 2020-12-21 | $65.07 | $3.9M | -3.4% | +2.8% | +4.9% |
| BBIO | SELL | 2020-12-15 | 2020-12-17 | $60.38 | $3.8M | +8.1% | +7.0% | +5.9% |
| BBIO | SELL | 2020-09-16 | 2020-09-18 | $37.50 | $938K | -10.1% | -5.2% | +54.4% |
| ALEC | SELL | 2020-02-04 | 2020-02-06 | $29.67 | $297K | -12.9% | -23.8% | -21.2% |
| XENE | BUY | 2017-08-10 | 2017-08-14 | $2.85 | $20K | +25.0% | +24.0% | -10.6% |
| DNA | SELL | 2008-07-16 | 2008-07-18 | $79.86 | $333K | -3.3% | -4.6% | -4.6% |
| DNA | SELL | 2008-06-06 | 2008-06-10 | $73.98 | $1.2M | -3.3% | -4.6% | -4.6% |
| DNA | SELL | 2008-02-27 | 2008-02-29 | $76.88 | $948K | -3.3% | -4.6% | -4.6% |
| DNA | SELL | 2008-02-27 | 2008-02-29 | $76.73 | $333K | -3.3% | -4.6% | -4.6% |
| DNA | SELL | 2007-10-22 | 2007-10-24 | $74.64 | $717K | -3.3% | -4.6% | -4.6% |
| DNA | SELL | 2007-10-22 | 2007-10-24 | $74.45 | $424K | -3.3% | -4.6% | -4.6% |
| DNA | SELL | 2007-10-22 | 2007-10-24 | $74.35 | $1.0M | -3.3% | -4.6% | -4.6% |
| DNA | SELL | 2007-10-22 | 2007-10-24 | $74.30 | $458K | -3.3% | -4.6% | -4.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.